Cargando…
Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China: a multicentre RCT study protocol
BACKGROUND: Pre-exposure prophylaxis (PrEP) is an effective biomedical strategy to prevent transmission of HIV infection, although medication adherence remains a challenge. We present the protocol for a multicentre randomised controlled trial to measure the effectiveness of a real-time monitoring an...
Autores principales: | Jin, Xia, Wang, Hongyi, Li, Hang, Chu, Zhenxing, Zhang, Jing, Hu, Qinghai, Lv, Wei, Huang, Xiaojie, Chen, Yaokai, Wang, Hui, He, Xiaoqing, Zhang, Lukun, Hu, Zhili, Bao, Rantong, Li, Shangcao, Ding, Haibo, Geng, Wenqing, Jiang, Yongjun, Shang, Hong, Xu, Junjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382059/ https://www.ncbi.nlm.nih.gov/pubmed/32709230 http://dx.doi.org/10.1186/s12889-020-08709-2 |
Ejemplares similares
-
Internet-Based HIV Self-Testing Among Men Who Have Sex With Men Through Pre-exposure Prophylaxis: 3-Month Prospective Cohort Analysis From China
por: Zhang, Jing, et al.
Publicado: (2021) -
HIV and other STIs self-testing to reduce risk compensation among men who have sex with men who use oral pre-exposure prophylaxis in China: protocol for a randomised waitlist-controlled trial
por: Zhang, Jing, et al.
Publicado: (2020) -
Risk-Taking Behaviors and Adherence to HIV Pre-Exposure Prophylaxis in Users of Geosocial Networking Apps: Real-World, Multicenter Study
por: Wang, Hongyi, et al.
Publicado: (2020) -
Correction: Risk-Taking Behaviors and Adherence to HIV Pre-Exposure Prophylaxis in Users of Geosocial Networking Apps: Real-World, Multicenter Study
por: Wang, Hongyi, et al.
Publicado: (2020) -
Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial
por: Wang, Hongyi, et al.
Publicado: (2022)